These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2684523)
1. Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Pollok M; Bommer J; Gurland HJ; Koch KM; Schoeppe W; Scigalla P; Baldamus CA Contrib Nephrol; 1989; 76():201-11; discussion 212-8. PubMed ID: 2684523 [No Abstract] [Full Text] [Related]
2. Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease. Scigalla P; Bonzel KE; Bulla M; Burghard R; Dippel J; Geisert J; Leumann E; von Lilien T; Müller-Wiefel DE; Offner G Contrib Nephrol; 1989; 76():227-40; discussion 240-1. PubMed ID: 2684524 [No Abstract] [Full Text] [Related]
3. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials. Sobota JT Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519 [No Abstract] [Full Text] [Related]
4. Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO. Suzuki M; Hirasawa Y; Hirashima K; Arakawa M; Odaka M; Ogura Y; Yoshikawa Y; Sanaka T; Shinoda A; Morii H Contrib Nephrol; 1989; 76():179-92; discussion 212-8. PubMed ID: 2684520 [No Abstract] [Full Text] [Related]
5. Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients. Buemi M; Allegra A; Aloisi C; Giacobbe MS; Frisina N Nephron; 1990; 56(2):218-9. PubMed ID: 2243581 [No Abstract] [Full Text] [Related]
6. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure]. Schaefer RM; Heidland A Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190 [No Abstract] [Full Text] [Related]
8. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
9. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia]. Nikolaev AIu; Klepikov PV; Lashutin SV Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349 [No Abstract] [Full Text] [Related]
10. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin. Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784 [No Abstract] [Full Text] [Related]
12. Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy. Lerche D; Schmidt R; Zoellner K; Meier W; Paulitschke M; Distler B; Klinkmann H Contrib Nephrol; 1989; 76():299-303; discussion 304-5. PubMed ID: 2684529 [No Abstract] [Full Text] [Related]
13. USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Eschbach JW; Downing MR; Egrie JC; Browne JK; Adamson JW Contrib Nephrol; 1989; 76():160-5; discussion 212-8. PubMed ID: 2684518 [No Abstract] [Full Text] [Related]
14. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
15. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis]. Fernández-Gallego J; Gutiérrez C Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885 [No Abstract] [Full Text] [Related]
16. [Therapy of renal anemia with recombinant human erythropoietin]. Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507 [TBL] [Abstract][Full Text] [Related]
18. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Korbet SM Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832 [No Abstract] [Full Text] [Related]
19. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin. Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565 [TBL] [Abstract][Full Text] [Related]
20. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]